摘要
Intraductal papillary mucinous neoplasm(IPMN) is a disease in evolution.Since its first description almost 30 years ago,a better understanding of the disease has steadily accrued.Yet,there are numerous challenges still for clinicians who treat this fascinating disease.A group of leading content experts on IPMN was assembled and charged with presenting cutting-edge knowledge on various topics for which they have considerable experience.This manuscript provides an historical perspective of both clinical and biological quandaries that have been resolved to date.Furthermore,it poses new avenues for investigation while highlighting the contributions of the various authors to this collective review.
Intraductal papillary mucinous neoplasm (IPMN) is a disease in evolution. Since its first description almost 30 years ago, a better understanding of the disease has steadily accrued. Yet, there are numerous challenges still for clinicians who treat this fascinating disease. A group of leading content experts on IPMN was assembled and charged with presenting cutting-edge knowledge on various topics for which they have considerable experience. This manuscript provides an historical perspective of both clinical and biological quandaries that have been resolved to date. Furthermore, it poses new avenues for investigation while highlighting the contributions of the various authors to this collective review.
